272 related articles for article (PubMed ID: 21724704)
21. Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Ferreira PL; Genrinho I; Santiago T; Carones A; Mazeda C; Barcelos A; Beirão T; Costa F; Santos I; Couto M; Rato M; Terroso G; Monteiro P
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674306
[TBL] [Abstract][Full Text] [Related]
22. Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
Zampatti N; Garaiman A; Jordan S; Dobrota R; Becker MO; Maurer B; Distler O; Mihai C
Arthritis Res Ther; 2021 Apr; 23(1):125. PubMed ID: 33888149
[TBL] [Abstract][Full Text] [Related]
23. Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database.
Baron M; Hudson M; Steele R;
J Rheumatol; 2009 Dec; 36(12):2737-43. PubMed ID: 19833750
[TBL] [Abstract][Full Text] [Related]
24. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.
Bodukam V; Hays RD; Maranian P; Furst DE; Seibold JR; Impens A; Mayes MD; Clements PJ; Khanna D
Rheumatology (Oxford); 2011 Feb; 50(2):330-4. PubMed ID: 20884655
[TBL] [Abstract][Full Text] [Related]
25. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.
Hesselstrand R; Nilsson JÅ; Sandqvist G
Scand J Rheumatol; 2013; 42(4):317-24. PubMed ID: 23442162
[TBL] [Abstract][Full Text] [Related]
26. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
[TBL] [Abstract][Full Text] [Related]
27. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
[TBL] [Abstract][Full Text] [Related]
28. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
Johnson SR; Glaman DD; Schentag CT; Lee P
J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
[TBL] [Abstract][Full Text] [Related]
29. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
[TBL] [Abstract][Full Text] [Related]
30. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
Sekhon S; Pope J; ; Baron M
J Rheumatol; 2010 Mar; 37(3):591-8. PubMed ID: 20080913
[TBL] [Abstract][Full Text] [Related]
31. Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis.
Bae S; Allanore Y; Furst DE; Bodukam V; Coustet B; Morgaceva O; Maranian P; Khanna D
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):57-63. PubMed ID: 23910611
[TBL] [Abstract][Full Text] [Related]
32. Sleep disturbances in systemic sclerosis: evidence for the role of gastrointestinal symptoms, pain and pruritus.
Milette K; Hudson M; Körner A; Baron M; Thombs BD;
Rheumatology (Oxford); 2013 Sep; 52(9):1715-20. PubMed ID: 23804222
[TBL] [Abstract][Full Text] [Related]
33. Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the University of California, San Diego, Shortness of Breath Questionnaire.
Chung L; Chen H; Khanna D; Steen VD
Arthritis Care Res (Hoboken); 2013 Mar; 65(3):454-63. PubMed ID: 23042670
[TBL] [Abstract][Full Text] [Related]
34. Validation of the Turkish version of the Quebec back pain disability scale for patients with low back pain.
Melikoglu MA; Kocabas H; Sezer I; Bilgilisoy M; Tuncer T
Spine (Phila Pa 1976); 2009 Mar; 34(6):E219-24. PubMed ID: 19282728
[TBL] [Abstract][Full Text] [Related]
35. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
[TBL] [Abstract][Full Text] [Related]
36. Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II.
Hudson M; Steele R; Taillefer S; Baron M;
Arthritis Rheum; 2008 Feb; 59(2):270-8. PubMed ID: 18240187
[TBL] [Abstract][Full Text] [Related]
37. [Reliability and validition of the Slovak modified version of the Stanford Health Assessment Questionnaire using the functional disability index in patients with rheumatoid arthritis].
Szilasiová A; Macejová Z; Nagyová I; Kovarová M; Béresová A; Szilasiová J
Vnitr Lek; 2002 Jan; 48(1):8-16. PubMed ID: 11852593
[TBL] [Abstract][Full Text] [Related]
38. Using a self-reported functional score to assess disease progression in systemic sclerosis.
Serednicka K; Smyth AE; Black CM; Denton CP
Rheumatology (Oxford); 2007 Jul; 46(7):1107-10. PubMed ID: 17426141
[TBL] [Abstract][Full Text] [Related]
39. Association of pruritus with quality of life and disability in systemic sclerosis.
El-Baalbaki G; Razykov I; Hudson M; Bassel M; Baron M; Thombs BD;
Arthritis Care Res (Hoboken); 2010 Oct; 62(10):1489-95. PubMed ID: 20506531
[TBL] [Abstract][Full Text] [Related]
40. The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.
Sultan N; Pope JE; Clements PJ;
Rheumatology (Oxford); 2004 Apr; 43(4):472-8. PubMed ID: 14679295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
